0000000000490433

AUTHOR

Krilaviciute Agne

showing 2 related works from this author

Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.

2014

Lung cancer is the most common cancer-related death worldwide. In Germany it accounts for 25% of cancer deaths in men, and 14% in women. The aim of this study is to provide an overview of 5-year relative survival by sex, age, histology, and tumour stage in Germany representing a population of 26.7 million people.The study is based on a pooled German dataset including data from 12 population-based cancer registries covering around one third of the German population. A total of 132,612 patients diagnosed with lung cancer from 2002 to 2010 were included in the analysis. Survival estimates for the time period 2007-2010 were calculated using period analysis. Differences in survival between sexes…

Pulmonary and Respiratory MedicineGerontologyAdultMaleCancer ResearchLung NeoplasmsAdolescentPopulationAge adjustmentsymbols.namesakeYoung AdultSex FactorsGermanymedicineHumansPoisson regressionRegistrieseducationLung cancerAgedNeoplasm StagingAged 80 and overeducation.field_of_studyRelative survivalbusiness.industryAbsolute risk reductionAge FactorsCancerMiddle Agedmedicine.diseaseCancer registryOncologyPopulation SurveillancesymbolsFemalebusinessDemographyLung cancer (Amsterdam, Netherlands)
researchProduct

Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?

2016

Objectives To better understand the influence of prostate-specific antigen (PSA) screening and other health system determinants on prognosis of prostate cancer, up-to-date relative survival (RS), stage distributions, and trends in survival and incidence in Germany were evaluated and compared with the United States of America (USA). Patients and methods Incidence and mortality rates for Germany and the USA for the period 1999-2010 were obtained from the Centre for Cancer Registry Data at the Robert Koch Institute and the USA Surveillance Epidemiology and End Results (SEER) database. For analyses on stage and survival, data from 12 population-based cancer registries in Germany and from the SE…

OncologyAdultMalemedicine.medical_specialtyAdolescentUrologyPopulation03 medical and health sciencesProstate cancerYoung Adult0302 clinical medicineAge DistributionPredictive Value of TestsResidence CharacteristicsInternal medicineGermanymedicineSurveillance Epidemiology and End ResultsHumansMass Screening030212 general & internal medicineeducationMass screeningAgedNeoplasm Stagingeducation.field_of_studyRelative survivalbusiness.industryMortality rateIncidence (epidemiology)IncidenceProstatic NeoplasmsReproducibility of ResultsMiddle AgedProstate-Specific Antigenmedicine.diseasePrognosisUnited StatesCancer registry030220 oncology & carcinogenesisbusinessDemographySEER ProgramBJU international
researchProduct